Fig. 2: Semaphorin 7a expression drives poor outcomes in PPBC.
From: Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer
SEMA7A (M + S) staining in patients stratified by a Lymphovascular invasion, b Lymph node involvement, and c Recurrence status. d Dichotomization of PPBC with an optimal cutoff of 36% M + S for SEMA7A high significantly predicts for decreased recurrence-free survival. (inset) PPBC case that is 36% SEMA7A + . Scale bar = 10 um. *p < 0.05, **p < 0.01, one-tailed Student’s t-test, mean + SEM are presented.
